These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9568466

  • 1. Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
    Stelter F, Witt S, Fürll B, Jack RS, Hartung T, Schütt C.
    Eur J Clin Invest; 1998 Mar; 28(3):205-13. PubMed ID: 9568466
    [Abstract] [Full Text] [Related]

  • 2. Increment of plasma soluble CD14 level in carrageenan-primed endotoxin shock model mice.
    Hozumi H, Adachi Y, Murakami T, Miura NN, Ohno N.
    Biol Pharm Bull; 2006 May; 29(5):1015-21. PubMed ID: 16651737
    [Abstract] [Full Text] [Related]

  • 3. Endotoxin-neutralizing capacity of soluble CD14.
    Schütt C, Schilling T, Grunwald U, Schönfeld W, Krüger C.
    Res Immunol; 1992 Jan; 143(1):71-8. PubMed ID: 1373513
    [Abstract] [Full Text] [Related]

  • 4. Protection of mice from LPS-induced shock by CD14 antisense oligonucleotide.
    Furusako S, Takahashi T, Mori S, Takahashi Y, Tsuda T, Namba M, Mochizuki H.
    Acta Med Okayama; 2001 Apr; 55(2):105-15. PubMed ID: 11332197
    [Abstract] [Full Text] [Related]

  • 5. Human monocyte CD14 is upregulated by lipopolysaccharide.
    Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W.
    Infect Immun; 1996 May; 64(5):1762-9. PubMed ID: 8613389
    [Abstract] [Full Text] [Related]

  • 6. Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.
    Hermann C, Spreitzer I, Schröder NW, Morath S, Lehner MD, Fischer W, Schütt C, Schumann RR, Hartung T.
    Eur J Immunol; 2002 Feb; 32(2):541-51. PubMed ID: 11828371
    [Abstract] [Full Text] [Related]

  • 7. Function of soluble CD14 in serum from patients with septic shock.
    Landmann R, Reber AM, Sansano S, Zimmerli W.
    J Infect Dis; 1996 Mar; 173(3):661-8. PubMed ID: 8627030
    [Abstract] [Full Text] [Related]

  • 8. LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in kupffer cells.
    Lichtman SN, Wang J, Lemasters JJ.
    Am J Physiol; 1998 Jul; 275(1):G39-46. PubMed ID: 9655682
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A.
    J Immunol; 1992 Aug 01; 149(3):918-24. PubMed ID: 1378868
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T, Obata T, Kuwahara-Arai K, Tamura H, Hiramatsu K, Nagaoka I.
    Int Immunol; 2009 Aug 01; 21(8):905-12. PubMed ID: 19556302
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.